UPCOMING EVENTS
Recent News
Recently, a paper written by Rui Shang, et al. was published with the goal of sorting out and summarizing the relevant studies on breast cancer-related lymphedema (BCRL) using bibliometric analysis. This paper reflects which authors, papers, institutions and countries contributed the most to the literature base for BCRL and also explores future research trends. The authors studied 1,000 relevant papers which contributed to this topic, which were written by 3,830 authors from hundreds of institutions in countries all over the world, published from 2003 to 2024.
The paper ranked the top 15 authors (top 0.39%), among the 3,830 authors, who contributed the most to the BCRL literature and with the highest impact. Our team was mentioned as the number 1 (A. Taghian), #3 (C. Brunelle; co-director of the program), #11 (G. Naoum) and #12 (M. Skolny). Naoum and Skolny were both mentees of Dr. Taghian who rotated through the program. In addition, members of the MGH team were ranked #2, 4, 7 and 13 (Brunelle, Taghian and Naoum) in terms of the centrality (impact) of the research.
Click the links below to read more about how our team has significantly impacted the field of breast cancer-related lymphedema!
PREVIOUS CONFERENCES AND EVENTS
International Breast Cancer Conference
October 2024
Our associate director, Dr. Alphonse Taghian, was invited to be a plenary session speaker at the 2024 International Breast Cancer Conference in Jeddah, Saudi Arabia!
Dr. Taghian presented 'Who is currently eligible for axillary surgical de-escalation (omission of axillary dissection and/or sentinel node biopsy)? Perspectives from Radiation Oncology' as well as 'New Approaches for Decreasing Risk of Lymphedema.'
Australasian Lymphology Association Conference
May 2024
Our associate director, Cheryl Brunelle, was invited to speak as the Keynote Speaker at the 15th Australasian Lymphology Association Conference in Adelaide, Australia on May 1-5, 2024! See below for more information on presentations.
Keynote: Precautionary Measures for Breast Cancer-Related Lymphoedema: Myths, Facts and Keeping the Patient Central
Plenary: Diagnostic criteria for breast cancer-related lymphoedema: The call for universal agreement
Plenary: Prospective screening and early intervention for breast cancer-related lymphoedema: Driving long-term outcomes
Expert Panel: Prospective screening and early intervention for breast cancer-related lymphoedema: Driving long-term outcomes
Consumer Day: Precautionary Measures for Breast Cancer-Related Lymphoedema: Myths, Facts and Informing Patient Autonomy
Boston Lymphatic Symposium
November 2023
Cheryl Brunelle was invited to present ‘Prospective Surveillance, Early Detection and Diagnosis’ at the 2023 Boston Lymphatic Symposium.
ALERT and MGH at Beacon Hill
November 2023
Our team was delighted to host colleagues Louise Koelmeyer, Robbie Blackwell and Fiona Tisdale Blake, of the ALERT team from Macquarie University in Sydney, Australia, at MGH on Monday. We always enjoy our collaborations with this amazing team!
Forward Momentum: Future Steps in Lymphedema Management
October 2023
Our associate director, Cheryl Brunelle, was invited to attend the Forward Momentum: Future Steps in Lymphedema Management summit hosted by the Lymphology Association of North America in collaboration with the American Cancer Society (ACS) hosted at Washington University in St. Louis, on October 7, 2023. Researchers, training program directors, representatives from lymphedema related non-profit organizations, surgeons and physicians came together to present clinically relevant research, attend the sessions, and engage in workshops to synthesize evidence, evaluate current best practices, and identify strategies to move the field of lymphology forward.
9th CUHK/HKBCF Breast Cancer Conference
October 2023
Dr. Alphonse Taghian was invited to the Chinese University of Hong Kong / Hong Kong Breast Cancer Foundation Breast Conference which took place on October 28-29, 2023. There, Dr. Taghian gave four presentations to raise awareness of Breast Cancer-Related Lymphedema, describe risk factors, and explain how a lymphedema screening program can be established.
15th Annual International Breast Cancer Conference & 2nd Breast Cancer Survivorship Summit
October 2023
Dr. Alphonse Taghian in Jeddah, Saudi Arabia attending the 15th Annual International Breast Cancer Conference & 2nd Breast Cancer Survivorship Summit held on October 12-14, 2023. Dr. Taghian presented on Breast Cancer-Related Lymphedema to spread awareness throughout Saudi Arabia, and his talk was very well recieved!
International Lymphoedema Framework Conference
June 2023
Dr. Alphonse Taghian and Cheryl Brunelle in Nottingham, UK speaking at the 11th International Lymphoedema Framework Conference held on June 13 - 15, 2023.
Dr. Alphonse Taghian guest lectures at Boston College
March 2023
Dr. Alphonse Taghian guest lectured at Boston College discussing breast cancer from a physician’s perspective.
Henri Mondor Breast Center and Radiation Oncology Center, Paris
January 2023
Dr. Alphonse Taghian spoke at the Radiation Department at Henri Mondor Hospital. He presented on how to set up a lymphedema screening program and the risk factors in developing lymphedema. Both parties discussed the differences of the transatlantic practices and how they can apply to one another in the future to accentuate patient health and quality of life.
San Antonio Breast Cancer Symposium
December 2022
Our team presented 3 posters at the 2022 San Antonio Breast Cancer Symposium. Check out the links below for more information on each poster:
Ipsilateral Infusions Are Not Associated with Increased Risk of Breast Cancer-Related Lymphedema in Patients Enrolled in a Prospective Screening Program - Presented by Cheryl Brunelle
The Impact of Adjuvant Chemotherapy, Including Taxanes, on Breast Cancer-Related Lymphedema Risk - Presented by Amanda Jung
Side Effects of the mRNA COVID-19 Vaccines in Women Treated for Breast Cancer: LymphVAX Study - Presented by Brooke Juhel
National Lymphedema Network's Cleveland Clinic Lymphatic Conference
November 2022
Cheryl Brunelle participated in an expert panel discussion regarding the State of Complete Decongestive Therapy for lymphedema treatment. This panel of certified therapists revisited the necessary parameters of treatment to maximize patient outcomes and discussed barriers to care at this challenging time in the healthcare system.
Bangladesh Society for Breast Cancer Study
November 2022
